http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2377569-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_92e4a950dfbe61eac5d4eaf36dd1014c
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577
filingDate 2008-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2009-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_030a67fb6c2a34921730bd93701e6b31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3d0cf1282238e4456ad07ef55ed1721
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_acfa357414fbfbed386d8d7c86a3fab6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72ecee6ace69085481e485d016258292
publicationDate 2009-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2377569-C1
titleOfInvention Method for predicting clinical effectiveness in severe gestoses
abstract FIELD: medicine. n SUBSTANCE: invention refers to medicine, namely to obstetrics and can be used in the 3 rd trimester of pregnancy for predicting clinical effectiveness in severe gestosis. Substance of the invention consists in that starting from 28 weeks of pregnancy peripheral venous blood of a woman suffering from severe gestosis is analysed for the content of CD16+CD3-cells. If the related values are less than 9%, conventional therapy of severe gestosis is predicted as efficient, while the value 9% or more show the absence of clinical effectiveness in gestosis. n EFFECT: application of the method allows predicting effectiveness of conventional therapy in severe gestosis from 28 weeks of pregnancy with high accuracy, sensitivity and specificity that enable to determine approach to further prenatal care and delivery, to reduce risk of fetal pathology, maternal and perinatal mortality. n 1 tbl, 3 ex
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2705374-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2475753-C1
priorityDate 2008-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419479210
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID457553
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00795
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100689317
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ1L9E4
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ4LAL9
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID8622052
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID282883
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID483662
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID45268
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9MZS8
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP07339
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396090
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID180559
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO93428
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO76856
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID81782
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP24268
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID20652
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID6646
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1509
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP18242
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID504287
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID13033
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ05744
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID490325
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9DEX3

Total number of triples: 43.